Natural killer cell subsets in man and rodents

Tissue Antigens

Volumn 78, Issue 2, 2011, Pages 81-88

  Inngjerdingen, M ^a   Kveberg, L ^a   Naper, C ^a   Vaage, J T ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Human; Mouse; NK cell receptors; NK cell subsets; Rat

Indexed keywords

CD11B ANTIGEN; CD161 ANTIGEN; CD27 ANTIGEN; CD56 ANTIGEN; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR3; CYTOCHROME P450 2B4; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; L SELECTIN; LEUKOCYTE ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D;

BLOOD; CELL FUNCTION; CYTOTOXICITY; EFFECTOR CELL; HUMAN; IMMUNITY; LIGAND BINDING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPLEEN; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD56; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INFLAMMATION; KILLER CELLS, NATURAL; MICE; PHENOTYPE; PROTEIN BINDING; RATS;

RATTUS; RODENTIA;

EID: 79960016933     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01714.x     Document Type: Review

References (57)

1. Lanier LL. NK cell recognition. Annu Rev Immunol 2005: 23: 225-34.
2. Dissen E, Fossum S, Hoelsbrekken SE, Saether PC. NK cell receptors in rodents and cattle. Semin Immunol 2008: 20: 369-75.
3. Ljunggren HG, Kärre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990: 11: 237-44.
4. Kim S, Poursine-Laurent J, Truscott SM et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005: 436: 709-13.
5. Anfossi N, Andre P, Guia S et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006: 25: 331-2.
6. Hoelsbrekken SE, Nylenna Ø, Saether PC et al. Cutting edge: molecular cloning of a killer cell Ig-like receptor in the mouse and rat. J Immunol 2003: 170: 2259-63.
7. Naper C, Hayashi S, Kveberg L et al. Ly-49s3 is a promiscuous activating rat NK cell receptor for nonclassical MHC class I-encoded target ligands. J Immunol 2002: 169: 22-30.
8. Naper C, Hayashi S, Joly E et al. Ly49i2 is an inhibitory rat natural killer cell receptor for an MHC class Ia molecule (RT1-A1c). Eur J Immunol 2002: 32: 2031-6.
9. Yokoyama WM, Seaman WE. The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu Rev Immunol 1993: 11: 613-35.
10. Aldemir H, Prod'homme V, Dumaurier MJ et al. Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J Immunol 2005: 175: 7791-5.
11. Rosen DB, Bettadapura J, Alsharifi M, Mathew PA, Warren HS, Lanier LL. Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor. J Immunol 2005: 175: 7796-9.
12. Eichler W, Ruschpler P, Wobus M, Drossler K. Differentially induced expression of C-type lectins in activated lymphocytes. J Cell Biochem Suppl 2001: 36: 201-8.
13. Carlyle JR, Jamieson AM, Gasser S, Clingan CS, Arase H, Raulet DH. Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors. Proc Natl Acad Sci U S A 2004: 101: 3527-32.
14. Kveberg L, Dai KZ, Westgaard IH et al. Two major groups of rat NKR-P1 receptors can be distinguished based on chromosomal localization, phylogenetic analysis and Clr ligand binding. Eur J Immunol 2009: 39: 541-51.
15. Kveberg L, Dai KZ, Inngjerdingen M, Brooks CG, Fossum S, Vaage JT. Phylogenetic and functional conservation of the NKR-P1F and -G receptors in rat and mouse. Immunogenetics 2011. In press. DOI: 10.1007/s00251-011-0520-1
16. Iizuka K, Naidenko OV, Plougastel BF, Fremont DH, Yokoyama WM. Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors. Nat Immunol 2003: 4: 801-7.
17. Kveberg L, Bäck CJ, Dai KZ et al. The novel inhibitory NKR-P1C receptor and Ly49s3 identify two complementary, functionally distinct NK cell subsets in rats. J Immunol 2006: 176: 4133-40.
18. Voigt S, Mesci A, Ettinger J et al. Cytomegalovirus evasion of innate immunity by subversion of the NKR-P1B:Clr-b missing-self axis. Immunity 2007: 26: 617-27.
19. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002: 195: 343-51.
20. Westgaard IH, Berg SF, Vaage JT et al. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta. J Leukoc Biol 2004: 76: 1200-6.
21. Walzer T, Blery M, Chaix J et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc Natl Acad Sci U S A 2007: 104: 3384-9.
22. Satoh-Takayama N, Lesjean-Pottier S, Sawa S, Vosshenrich CA, Eberl G, Di Santo JP. Lymphotoxin-beta receptor-independent development of intestinal IL-22-producing NKp46(+) innate lymphoid cells. Eur J Immunol 2011: 41: 780-6.
23. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 1986: 136: 4480-6.
24. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001: 22: 633-40.
25. Robertson MJ, Soiffer RJ, Wolf SF et al. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 1992: 175: 779-88.
26. Fauriat C, Long EO, Ljunggren HG, Bryceson YT. Regulation of human NK cell cytokine and chemokine production by target cell recognition. Blood 2010: 115: 2167-76.
27. De MA, Bozzano F, Cantoni C, Moretta L. Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. Proc Natl Acad Sci U S A 2011: 108: 728-32.
28. + NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001: 166: 6477-82.
29. Ferlazzo G, Thomas D, Lin SL et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 2004: 172: 1455-62.
30. Kim S, Iizuka K, Kang HS et al. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 2002: 3: 523-8.
31. Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006: 176: 1517-24.
32. Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, Walzer T. Maturation of mouse NK cells is a 4-stage developmental program. Blood 2009: 113: 5488-96.
33. Watt SV, Andrews DM, Takeda K, Smyth MJ, Hayakawa Y. IFN-gamma-dependent recruitment of mature CD27(high) NK cells to lymph nodes primed by dendritic cells. J Immunol 2008: 181: 5323-30.
34. Silva A, Andrews DM, Brooks AG, Smyth MJ, Hayakawa Y. Application of CD27 as a marker for distinguishing human NK cell subsets. Int Immunol 2008: 20: 625-30.
35. Vossen MT, Matmati M, Hertoghs KM et al. CD27 defines phenotypically and functionally different human NK cell subsets. J Immunol 2008: 180: 3739-45.
36. Martin-Fontecha A, Thomsen LL, Brett S et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004: 5: 1260-5.
37. Vosshenrich CA, Garcia-Ojeda ME, Samson-Villeger SI et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat Immunol 2006: 7: 1217-24.
38. +, differ in phenotypic characteristics and responsiveness to cytokines. J Leukoc Biol 2010: 88: 87-93.
39. Aust JG, Gays F, Mickiewicz KM, Buchanan E, Brooks CG. The expression and function of the NKRP1 receptor family in C57BL/6 mice. J Immunol 2009: 183: 106-16.
40. Haller O, Wigzell H. Suppression of natural killer cell activity with radioactive strontium: effector cells are marrow dependent. J Immunol 1977: 118: 1503-6.
41. Vosshenrich CA, Samson-Villéger SI, Di Santo JP. Distinguishing features of developing natural killer cells. Curr Opin Immunol 2005: 17: 151-8.
42. Freud AG, Yokohama A, Becknell B et al. Evidence for discrete stages of human natural killer cell differentiation in vivo. J Exp Med 2006: 203: 1033-43.
43. dim NK cells upon activation. J Immunol 2007: 178: 4947-55.
44. dim cells: role of contact with peripheral fibroblasts. J Immunol 2007: 179: 89-94.
45. dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010: 116: 3853-64.
46. + NK-cell subset. Blood 2010: 116: 3865-74.
47. dim NK cells. Blood 2010: 116: 1299-307.
48. dim human NK-cell subsets. Blood 2010: 115: 274-81.
49. Hamann I, Unterwalder N, Cardona AE et al. Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells. Immunology 2011: 133: 62-73.
50. +high stage and effector functions. J Immunol 2004: 172: 88-96.
51. de Matos CT, Berg L, Michaëlsson J, Fellander-Tsai L, Kärre K, Söderström K. Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion. Immunology 2007: 122: 291-301.
52. Belisle JA, Gubbels JA, Raphael CA et al. Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125). Immunology 2007: 122: 418-29.
53. + T-cells in sarcoidosis patients. Eur Respir J 2005: 26: 77-85.
54. Golden-Mason L, Madrigal-Estebas L, McGrath E et al. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 2008: 57: 1121-8.
55. Brady J, Carotta S, Thong RP et al. The interactions of multiple cytokines control NK cell maturation. J Immunol 2010: 185: 6679-88.
56. Brauner H, Elemans M, Lemos S et al. Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice. J Immunol 2010: 184: 2272-80.
57. Sun JC, Lopez-Verges S, Kim CC, Derisi JL, Lanier LL. NK cells and immune "memory". J Immunol 2011: 186: 1891-7.